Glonghui, August 20th — Moderna shares fell over 10% in U.S. pre-market trading, after surging more than 176% yesterday.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.